Advanced Medical Solutions bullish on future
Wounds treatment firm Advanced Medical Solutions was in demand after it posted a jump in profits and raised its dividend.
Wounds treatment firm Advanced Medical Solutions was in demand after it posted a jump in profits and raised its dividend.
Profit before tax was up 72% to £4.5m on revenues that were up 52% to £24.8m in the first half of the year.
The firm pushed up its interim dividend to 0.17p per share, an increase of 17.2% on the year before.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Chairman, Dr Don Evans, said the first half of 2012 hd seen significant progress by AMS, with its product LiquiBand continuing to increase its market share in the US.
"Despite the ongoing effects of the Euro on revenues, as highlighted previously, we expect to meet current market expectations for profit for the full-year," he said."
Evans also noted a strong performance by its wound dressing ActivHeal in the UK and an excellent initial contribution from the firm's recent acquisition of German firm Resorba.
"The second half is also expected to benefit from stronger silver alginate sales, initial trilaminate foam revenues and an additional boost in the US from LiquiBand Flex," he said.
"Further out, we have a number of exciting developments coming through our R&D pipeline which, combined with further strong progress anticipated in our existing businesses, lead the board to be very optimistic about our long term prospects," the Chairman added.
The company's shares rose almost 12% following the news.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
-
Cash in on the growth prospects of Europe's companies
Opinion Marcel Stötzel, co-portfolio manager of the Fidelity European Trust, selects three stocks
By Marcel Stotzel Published
-
Is the AI boom another dotcom bubble?
25 years on from the dotcom bubble bursting, is it time for investors to consider the sustainability of the AI boom in the stock market?
By Dan McEvoy Published